Advertisement
Advertisement
At close: 04:03PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 50.65 |
| Open | 51.26 |
| Bid | 53.87 x 1800 |
| Ask | 53.98 x 4000 |
| Day's Range | 51.13 - 52.70 |
| 52 Week Range | 38.48 - 61.71 |
| Volume | |
| Avg. Volume | 27,271,677 |
| Market Cap | 302.59B |
| Beta (5Y Monthly) | 0.72 |
| PE Ratio (TTM) | 15.40 |
| EPS (TTM) | 3.50 |
| Earnings Date | May 02, 2022 - May 06, 2022 |
| Forward Dividend & Yield | 1.60 (3.21%) |
| Ex-Dividend Date | May 12, 2022 |
| 1y Target Est | 59.33 |
- Insider Monkey
Top 10 Value Stocks Hedge Funds are Buying in 2022
In this article, we discuss the top 10 value stocks hedge funds are buying in 2022. If you want to see more of the value stocks that elite investors are favoring, click Top 5 Value Stocks Hedge Funds are Buying in 2022. As the Federal Reserve signals further monetary tightening, hedge funds and retail investors […]
- Zacks
Pfizer (PFE) Gets Fast Track Designation for NASH Therapy
Pfizer (PFE) obtains Fast Track designation for its investigational combination therapy - ervogastat and clesacostat for the treatment of NASH.
- Zacks
Pharma Stock Roundup: EU Nod for AZN, JNJ & Others, PFE COVID Jab Effective in Kids
European Commission authorizes a booster dose of AstraZeneca's (AZN) COVID-19 vaccine and approves Merck (MRK) and Roche's (RHHBY) oncology drugs for expanded use.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
